Jonathan K. Muraskas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jonathan K. Muraskas has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
Craig L. Anderson
2 shared publicationsJohn C. Morrison
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson, Mississippi
2 shared publicationsLoretto Glynn
Department of Surgery, New York University Langone Health, New York, United States of America
2 shared publicationsOmar Habeeb
Department of Pathology, New York University Lagone Medical Center, New York, NY, USA
2 shared publicationsPamela Nicoski
2 shared publicationsPhillip J. DeChristopher
Department of Pathology, Loyola University Medical Center, Maywood, IL, USA
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by ASEAN Federation for Psychiatry and Mental Health
- Vol. 14 (2) , 01-05
Role of Maternal ABO Blood Type on Adverse Obstetric Outcomes
Objective: ABO blood types, particularly type AB, are associated with many disease states, including various cancers, coagulopathies, viral susceptibilities, and some endocrine disorders. The relationship of maternal ABO blood type and adverse obstetrical outcomes has yet to be elucidated. This study evaluates the potential role of maternal ABO blood type on various adverse obstetrical outcomes for both mother and neonate. Study design: Data from 3,263 deliveries was obtained through electronic medical records at a single medical institution. Variables included maternal blood type, maternal age, Body Mass Index (BMI), gestational age at delivery, quantitative blood loss, mode of delivery, presence of Category 2 or 3 tracing, maternal pregnancy history, clinical chorioamnionitis diagnosis, Fetal Growth Restriction (FGR), stillbirth, Prolonged Rupture Of Membranes (PROM), Preterm Prelabor Rupture of Membranes (PPROM), indications for cesarean section, hypertensive disorders of pregnancy, and medical history including chronic hypertension, gestational and pre-gestational diabetes, thrombophilia, bleeding disorder, venous thromboembolism, seizure disorder, cholestasis of pregnancy, and COVID-19 infection history. Results: Patients with blood type AB had a gestational Hypertension (gHTN) rate of 14% compared to 9% in other blood types (p=0.059), which became significant (p=0.032) when controlling for age, BMI, and gestational age. There was no statistically significant association for the rate of preeclampsia and superimposed preeclampsia in blood type AB individuals vs. other (p=0.089), when controlling for age, BMI, and gestational age. No statistically significant association for any hypertensive disorder of pregnancy in blood type AB individuals vs. other (p=0.65) when controlling for age, BMI, and gestational age was found. Four-way comparisons between the 4 individual blood types (AB, A, B, O) did not show differences in any of the tested outcomes. Conclusion: Maternal AB blood type yields a potential positive association with gestational hypertension, however AB blood type has no other associations with any other hypertensive disorders of pregnancy. No other significant association was found between maternal blood type and adverse obstetrical outcomes. Physicians should not rely on maternal blood type as a reliable indicator of potential obstetrical outcomes or when identifying high-risk mothers. Keywords ABO blood type; Pregnancy; Maternal disease; Neonatal disease; Hypertensive disorders; Gestational hypertension
- 1 January 2025
- Published by ASEAN Federation for Psychiatry and Mental Health
- Vol. 14 (2) , 01-05
Open AccessRole of Maternal ABO Blood Type on Adverse Obstetric Outcomes
Objective: ABO blood types, particularly type AB, are associated with many disease states, including various cancers, coagulopathies, viral susceptibilities, and some endocrine disorders. The relationship of maternal ABO blood type and adverse obstetrical outcomes has yet to be elucidated. This study evaluates the potential role of maternal ABO blood type on various adverse obstetrical outcomes for both mother and neonate. Study design: Data from 3,263 deliveries was obtained through electronic medical records at a single medical institution. Variables included maternal blood type, maternal age, Body Mass Index (BMI), gestational age at delivery, quantitative blood loss, mode of delivery, presence of Category 2 or 3 tracing, maternal pregnancy history, clinical chorioamnionitis diagnosis, Fetal Growth Restriction (FGR), stillbirth, Prolonged Rupture Of Membranes (PROM), Preterm Prelabor Rupture of Membranes (PPROM), indications for cesarean section, hypertensive disorders of pregnancy, and medical history including chronic hypertension, gestational and pre-gestational diabetes, thrombophilia, bleeding disorder, venous thromboembolism, seizure disorder, cholestasis of pregnancy, and COVID-19 infection history. Results: Patients with blood type AB had a gestational Hypertension (gHTN) rate of 14% compared to 9% in other blood types (p=0.059), which became significant (p=0.032) when controlling for age, BMI, and gestational age. There was no statistically significant association for the rate of preeclampsia and superimposed preeclampsia in blood type AB individuals vs. other (p=0.089), when controlling for age, BMI, and gestational age. No statistically significant association for any hypertensive disorder of pregnancy in blood type AB individuals vs. other (p=0.65) when controlling for age, BMI, and gestational age was found. Four-way comparisons between the 4 individual blood types (AB, A, B, O) did not show differences in any of the tested outcomes. Conclusion: Maternal AB blood type yields a potential positive association with gestational hypertension, however AB blood type has no other associations with any other hypertensive disorders of pregnancy. No other significant association was found between maternal blood type and adverse obstetrical outcomes. Physicians should not rely on maternal blood type as a reliable indicator of potential obstetrical outcomes or when identifying high-risk mothers. Keywords ABO blood type; Pregnancy; Maternal disease; Neonatal disease; Hypertensive disorders; Gestational hypertension
- 30 November 2023
- Published by Loma Linda Publishing Company in Neonatology Today
Nucleated Red Blood Cells and the Timing of Hypoxic Ischemic Encephalopathy
The duration of an acute, hypoxic-ischemic event correlates to the quantity of nRBCs in the fetal/neonatal circulation and time resolution time (hours vs. days).
- 30 November 2023
- Published by Loma Linda Publishing Company in Neonatology Today
Nucleated Red Blood Cells and the Timing of Hypoxic Ischemic Encephalopathy
The duration of an acute, hypoxic-ischemic event correlates to the quantity of nRBCs in the fetal/neonatal circulation and time resolution time (hours vs. days).
- Open Access
- 29 March 2023
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology: X
- Vol. 18, 100191
Neonatal serial creatinine levels as an adjunct biomarker in timing of fetal neurologic injury
- 29 March 2023
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology: X
- Vol. 18, 100191
Open AccessNeonatal serial creatinine levels as an adjunct biomarker in timing of fetal neurologic injury
- 1 August 2020
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 25 (4) , 101142
FIRS: Neonatal considerations
- 1 August 2020
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 25 (4) , 101142
FIRS: Neonatal considerations
- 3 June 2019
- Published by Springer Nature in Pediatric Research
- Vol. 86 (3) , 316-322
ABO blood group and procoagulant factors: the hypercoagulation hypothesis ABO and Procoagulant Factors
Background The correlation between procoagulant levels—factor VIII (FVIII), von Willebrand factor (vWF), and fibrinogen—and risk of thrombosis has been well documented in adult populations. We hypothesize that interaction of passively transferred isoagglutinins in premature neonates with a compromised immune system may trigger an immune response that can target the immature gastrointestinal tract. The objective of this study is to evaluate if there are procoagulant level differences in preterm newborns stratified by ABO blood group. Methods VWF, FVIII, and fibrinogen levels were analyzed in neonates ≤32 weeks and/or birthweight ≤1500 g over the first 6 weeks of life. Demographic, blood type, and transfusion data were collected. Results Elevations in vWF and FVIII were found to be statistically significant in the third week of life in non-O neonates vs. type O neonates. FVIII was also found to be significantly elevated in week 1. Transfused neonates also showed elevations between weeks 0 and 3. Conclusion There appears to be a time-dependent variation in procoagulant factor levels in preterm newborns. Although the clinical significance remains unclear, prothrombotic factors vWF and FVIII are significantly higher in non-O blood-type preterm neonates in the third week of life.
- 3 June 2019
- Published by Springer Nature in Pediatric Research
- Vol. 86 (3) , 316-322
ABO blood group and procoagulant factors: the hypercoagulation hypothesis ABO and Procoagulant Factors
Background The correlation between procoagulant levels—factor VIII (FVIII), von Willebrand factor (vWF), and fibrinogen—and risk of thrombosis has been well documented in adult populations. We hypothesize that interaction of passively transferred isoagglutinins in premature neonates with a compromised immune system may trigger an immune response that can target the immature gastrointestinal tract. The objective of this study is to evaluate if there are procoagulant level differences in preterm newborns stratified by ABO blood group. Methods VWF, FVIII, and fibrinogen levels were analyzed in neonates ≤32 weeks and/or birthweight ≤1500 g over the first 6 weeks of life. Demographic, blood type, and transfusion data were collected. Results Elevations in vWF and FVIII were found to be statistically significant in the third week of life in non-O neonates vs. type O neonates. FVIII was also found to be significantly elevated in week 1. Transfused neonates also showed elevations between weeks 0 and 3. Conclusion There appears to be a time-dependent variation in procoagulant factor levels in preterm newborns. Although the clinical significance remains unclear, prothrombotic factors vWF and FVIII are significantly higher in non-O blood-type preterm neonates in the third week of life.
- 19 October 2018
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 12 (1) , 81-86
The association between AB blood group and neonatal disease
BACKGROUND: Numerous studies have examined the association between ABO blood groups and adult disease states, but very few have studied the neonatal population. The objective of this study was to determine the relationship between AB blood group and the occurrence of common neonatal disorders such as neutropenia at birth, sepsis, respiratory distress syndrome (RDS), intraventricular hemorrhage (IVH), retinopathy of prematurity (ROP), and patent ductus arteriosus (PDA) compared to all other blood groups. METHODS: We performed a retrospective review on 3,981 infants born at 22 0/7 to 42 6/7 weeks’ gestational age and compared the relative risk of neonatal diseases in infants with AB blood group to that of infants with all other blood groups (A, B, and O). RESULTS: When compared to all other blood groups, AB infants demonstrated an increased risk for developing negative clinical outcomes. AB blood group was significantly associated with a 14–89% increased risk of neutropenia at birth, sepsis, RDS, and ROP. Risks for IVH and PDA were not significant. CONCLUSION: We hypothesize that the phenotypic expression of A and B antigens, rather than the antigens themselves, in the AB group may reveal an enhanced susceptibility to injury at the endothelial level resulting in an increased risk for disease development.
- 19 October 2018
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 12 (1) , 81-86
The association between AB blood group and neonatal disease
BACKGROUND: Numerous studies have examined the association between ABO blood groups and adult disease states, but very few have studied the neonatal population. The objective of this study was to determine the relationship between AB blood group and the occurrence of common neonatal disorders such as neutropenia at birth, sepsis, respiratory distress syndrome (RDS), intraventricular hemorrhage (IVH), retinopathy of prematurity (ROP), and patent ductus arteriosus (PDA) compared to all other blood groups. METHODS: We performed a retrospective review on 3,981 infants born at 22 0/7 to 42 6/7 weeks’ gestational age and compared the relative risk of neonatal diseases in infants with AB blood group to that of infants with all other blood groups (A, B, and O). RESULTS: When compared to all other blood groups, AB infants demonstrated an increased risk for developing negative clinical outcomes. AB blood group was significantly associated with a 14–89% increased risk of neutropenia at birth, sepsis, RDS, and ROP. Risks for IVH and PDA were not significant. CONCLUSION: We hypothesize that the phenotypic expression of A and B antigens, rather than the antigens themselves, in the AB group may reveal an enhanced susceptibility to injury at the endothelial level resulting in an increased risk for disease development.
- 8 December 2014
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 32 (07) , 627-632
Influence of Perinatal Factors in Short- and Long-Term Outcomes of Infants Born at 23 Weeks of Gestation
Objective Investigate the influence of perinatal factors on short- and long-term outcomes for infants born at 23 weeks of gestation. Study Design This is a retrospective study over a 25-year period (1987–2011) of 87 successfully resuscitated infants at 23 weeks of gestation. We investigated the effects of poor prenatal care, race, gender, chorioamnionitis, antenatal corticosteroids, delivery route/location, low 5-minute Apgar score, birth weight, and multiple births on short- and long-term outcomes. Results The mortality rate was 43% (37/87). A total of 88% (44/50) of the survivors were followed at 2 years corrected age with 66% (29/44) diagnosed with a moderate-to-severe neurological impairment. Outborn and multiple birth infants had significantly higher mortality (p-value 0.042 and 0.006, respectively). Lack of exposure to antenatal steroids and lower birth weight significantly increased the disability score (p-value 0.042 and 0.003, respectively). Conclusion Multiple perinatal factors significantly influence outcomes at the threshold of viability.
- 8 December 2014
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 32 (07) , 627-632
Influence of Perinatal Factors in Short- and Long-Term Outcomes of Infants Born at 23 Weeks of Gestation
Objective Investigate the influence of perinatal factors on short- and long-term outcomes for infants born at 23 weeks of gestation. Study Design This is a retrospective study over a 25-year period (1987–2011) of 87 successfully resuscitated infants at 23 weeks of gestation. We investigated the effects of poor prenatal care, race, gender, chorioamnionitis, antenatal corticosteroids, delivery route/location, low 5-minute Apgar score, birth weight, and multiple births on short- and long-term outcomes. Results The mortality rate was 43% (37/87). A total of 88% (44/50) of the survivors were followed at 2 years corrected age with 66% (29/44) diagnosed with a moderate-to-severe neurological impairment. Outborn and multiple birth infants had significantly higher mortality (p-value 0.042 and 0.006, respectively). Lack of exposure to antenatal steroids and lower birth weight significantly increased the disability score (p-value 0.042 and 0.003, respectively). Conclusion Multiple perinatal factors significantly influence outcomes at the threshold of viability.
- 1 August 2014
- Published by Elsevier in Journal of Critical Care
- Vol. 29 (4) , 691.e1-691.e5
Measurement of the glucocorticoid receptor: Relevance to the diagnosis of critical illness–related corticosteroid insufficiency in children
- 1 August 2014
- Published by Elsevier in Journal of Critical Care
- Vol. 29 (4) , 691.e1-691.e5
Measurement of the glucocorticoid receptor: Relevance to the diagnosis of critical illness–related corticosteroid insufficiency in children
- 1 February 2014
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 49 (2) , 273-276
The relationship between reticulated platelets, intestinal alkaline phosphatase, and necrotizing enterocolitis
- 1 February 2014
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 49 (2) , 273-276
The relationship between reticulated platelets, intestinal alkaline phosphatase, and necrotizing enterocolitis